Logo image of ESTA

ESTABLISHMENT LABS HOLDINGS (ESTA) Stock Fundamental Analysis

NASDAQ:ESTA - Nasdaq - VGG312491084 - Common Stock - Currency: USD

31.2  +0.85 (+2.8%)

Fundamental Rating

3

Taking everything into account, ESTA scores 3 out of 10 in our fundamental rating. ESTA was compared to 189 industry peers in the Health Care Equipment & Supplies industry. Both the profitability and financial health of ESTA have multiple concerns. ESTA is quite expensive at the moment. It does show a decent growth rate.


Dividend Valuation Growth Profitability Health

Quickly go to:

1

1. Profitability

1.1 Basic Checks

ESTA had negative earnings in the past year.
ESTA had a negative operating cash flow in the past year.
ESTA had negative earnings in each of the past 5 years.
In the past 5 years ESTA always reported negative operating cash flow.
ESTA Yearly Net Income VS EBIT VS OCF VS FCFESTA Yearly Net Income VS EBIT VS OCF VS FCFYearly Net Income VS EBIT VS OCF VS FCF 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 -20M -40M -60M -80M -100M

1.2 Ratios

With a Return On Assets value of -24.39%, ESTA perfoms like the industry average, outperforming 48.68% of the companies in the same industry.
ESTA's Return On Equity of -159.33% is on the low side compared to the rest of the industry. ESTA is outperformed by 69.31% of its industry peers.
Industry RankSector Rank
ROA -24.39%
ROE -159.33%
ROIC N/A
ROA(3y)-29.75%
ROA(5y)-28.61%
ROE(3y)N/A
ROE(5y)N/A
ROIC(3y)N/A
ROIC(5y)N/A
ESTA Yearly ROA, ROE, ROICESTA Yearly ROA, ROE, ROICYearly ROA, ROE, ROIC 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 200 -200 400 -400 600 800

1.3 Margins

ESTA's Gross Margin of 65.97% is fine compared to the rest of the industry. ESTA outperforms 68.78% of its industry peers.
ESTA's Gross Margin has been stable in the last couple of years.
ESTA does not have Profit Margin and Operating Margin available, so we won't be analyzing them here.
Industry RankSector Rank
OM N/A
PM (TTM) N/A
GM 65.97%
OM growth 3YN/A
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3Y-0.71%
GM growth 5Y1.49%
ESTA Yearly Profit, Operating, Gross MarginsESTA Yearly Profit, Operating, Gross MarginsYearly Profit, Operating, Gross Margins 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 50 -50 -100

More info and screens

3

2. Health

2.1 Basic Checks

ESTA does not have a ROIC to compare to the WACC, probably because it is not profitable.
ESTA has more shares outstanding than it did 1 year ago.
The number of shares outstanding for ESTA has been increased compared to 5 years ago.
The debt/assets ratio for ESTA has been reduced compared to a year ago.
ESTA Yearly Shares OutstandingESTA Yearly Shares OutstandingYearly Shares Outstanding 2016 2017 2018 2019 2020 2021 2022 2023 2024 5M 10M 15M 20M 25M
ESTA Yearly Total Debt VS Total AssetsESTA Yearly Total Debt VS Total AssetsYearly Total Debt VS Total Assets 2016 2017 2018 2019 2020 2021 2022 2023 2024 100M 200M 300M

2.2 Solvency

ESTA has an Altman-Z score of 0.60. This is a bad value and indicates that ESTA is not financially healthy and even has some risk of bankruptcy.
ESTA has a Altman-Z score (0.60) which is in line with its industry peers.
A Debt/Equity ratio of 4.14 is on the high side and indicates that ESTA has dependencies on debt financing.
Looking at the Debt to Equity ratio, with a value of 4.14, ESTA is doing worse than 87.83% of the companies in the same industry.
Industry RankSector Rank
Debt/Equity 4.14
Debt/FCF N/A
Altman-Z 0.6
ROIC/WACCN/A
WACC8.52%
ESTA Yearly LT Debt VS Equity VS FCFESTA Yearly LT Debt VS Equity VS FCFYearly LT Debt VS Equity VS FCF 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 100M -100M 200M

2.3 Liquidity

A Current Ratio of 3.56 indicates that ESTA has no problem at all paying its short term obligations.
With a decent Current ratio value of 3.56, ESTA is doing good in the industry, outperforming 60.32% of the companies in the same industry.
A Quick Ratio of 2.41 indicates that ESTA has no problem at all paying its short term obligations.
Looking at the Quick ratio, with a value of 2.41, ESTA is in line with its industry, outperforming 55.03% of the companies in the same industry.
Industry RankSector Rank
Current Ratio 3.56
Quick Ratio 2.41
ESTA Yearly Current Assets VS Current LiabilitesESTA Yearly Current Assets VS Current LiabilitesYearly Current Assets VS Current Liabilites 2016 2017 2018 2019 2020 2021 2022 2023 2024 50M 100M 150M 200M

More info and screens

6

3. Growth

3.1 Past

ESTA shows a small growth in Earnings Per Share. In the last year, the EPS has grown by 1.97%.
The Revenue has been growing slightly by 0.53% in the past year.
ESTA shows quite a strong growth in Revenue. Measured over the last years, the Revenue has been growing by 13.13% yearly.
EPS 1Y (TTM)1.97%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%-50.63%
Revenue 1Y (TTM)0.53%
Revenue growth 3Y9.43%
Revenue growth 5Y13.13%
Sales Q2Q%41.05%

3.2 Future

ESTA is expected to show a strong growth in Earnings Per Share. In the coming years, the EPS will grow by 25.95% yearly.
Based on estimates for the next years, ESTA will show a very strong growth in Revenue. The Revenue will grow by 33.73% on average per year.
EPS Next Y29.38%
EPS Next 2Y27.25%
EPS Next 3Y24.91%
EPS Next 5Y25.95%
Revenue Next Year24.5%
Revenue Next 2Y24.66%
Revenue Next 3Y24.27%
Revenue Next 5Y33.73%

3.3 Evolution

The Revenue growth rate is accelerating: in the next years the growth will be better than in the last years.
ESTA Yearly Revenue VS EstimatesESTA Yearly Revenue VS EstimatesYearly Revenue VS Estimates 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 2026 2027 2028 2030 200M 400M 600M
ESTA Yearly EPS VS EstimatesESTA Yearly EPS VS EstimatesYearly EPS VS Estimates 2018 2019 2020 2021 2022 2023 2024 2025 2026 2027 2028 0 1 -1 -2 -3

More info and screens

1

4. Valuation

4.1 Price/Earnings Ratio

The Price/Earnings Ratio is negative for ESTA. In the last year negative earnings were reported.
Also next year ESTA is expected to report negative earnings again, which makes the also the Forward Price/Earnings Ratio negative.
Industry RankSector Rank
PE N/A
Fwd PE N/A
ESTA Price Earnings VS Forward Price EarningsESTA Price Earnings VS Forward Price Earnings ChartPrice Earnings - Forward Price Earnings PE FPE 0 20 40

4.2 Price Multiples

Industry RankSector Rank
P/FCF N/A
EV/EBITDA N/A
ESTA Per share dataESTA EPS, Sales, OCF, FCF, BookValue per sharePer Share Data Per Share 0 2 -2 4

4.3 Compensation for Growth

A more expensive valuation may be justified as ESTA's earnings are expected to grow with 24.91% in the coming years.
PEG (NY)N/A
PEG (5Y)N/A
EPS Next 2Y27.25%
EPS Next 3Y24.91%

More info and screens

0

5. Dividend

5.1 Amount

No dividends for ESTA!.
Industry RankSector Rank
Dividend Yield N/A

More info and screens

ESTABLISHMENT LABS HOLDINGS

NASDAQ:ESTA (5/1/2025, 2:59:15 PM)

31.2

+0.85 (+2.8%)

Chartmill FA Rating
GICS SectorHealth Care
GICS IndustryGroupHealth Care Equipment & Services
GICS IndustryHealth Care Equipment & Supplies
Earnings (Last)02-26 2025-02-26/amc
Earnings (Next)05-07 2025-05-07/amc
Inst Owners106.27%
Inst Owner Change-0.27%
Ins Owners6.84%
Ins Owner Change0.22%
Market Cap901.99M
Analysts84.62
Price Target56.1 (79.81%)
Short Float %19.43%
Short Ratio7.66
Dividend
Industry RankSector Rank
Dividend Yield N/A
Yearly DividendN/A
Dividend Growth(5Y)N/A
DPN/A
Div Incr Years0
Div Non Decr Years0
Ex-DateN/A
Surprises & Revisions
EPS beat(2)1
Avg EPS beat(2)-34.55%
Min EPS beat(2)-75.04%
Max EPS beat(2)5.95%
EPS beat(4)2
Avg EPS beat(4)-18.22%
Min EPS beat(4)-75.04%
Max EPS beat(4)14.93%
EPS beat(8)5
Avg EPS beat(8)-6.66%
EPS beat(12)7
Avg EPS beat(12)-25.46%
EPS beat(16)9
Avg EPS beat(16)-25.71%
Revenue beat(2)0
Avg Revenue beat(2)-2.33%
Min Revenue beat(2)-2.5%
Max Revenue beat(2)-2.16%
Revenue beat(4)2
Avg Revenue beat(4)-0.77%
Min Revenue beat(4)-2.5%
Max Revenue beat(4)1.21%
Revenue beat(8)4
Avg Revenue beat(8)-1.32%
Revenue beat(12)7
Avg Revenue beat(12)0.13%
Revenue beat(16)10
Avg Revenue beat(16)1.6%
PT rev (1m)-5.64%
PT rev (3m)-8.77%
EPS NQ rev (1m)-0.39%
EPS NQ rev (3m)-31.14%
EPS NY rev (1m)-0.79%
EPS NY rev (3m)-11.68%
Revenue NQ rev (1m)0.84%
Revenue NQ rev (3m)-4.39%
Revenue NY rev (1m)-0.18%
Revenue NY rev (3m)0.3%
Valuation
Industry RankSector Rank
PE N/A
Fwd PE N/A
P/S 5.43
P/FCF N/A
P/OCF N/A
P/B 16.99
P/tB 22.44
EV/EBITDA N/A
EPS(TTM)-2.98
EYN/A
EPS(NY)-2.1
Fwd EYN/A
FCF(TTM)-2.56
FCFYN/A
OCF(TTM)-2.02
OCFYN/A
SpS5.74
BVpS1.84
TBVpS1.39
PEG (NY)N/A
PEG (5Y)N/A
Profitability
Industry RankSector Rank
ROA -24.39%
ROE -159.33%
ROCE N/A
ROIC N/A
ROICexc N/A
ROICexgc N/A
OM N/A
PM (TTM) N/A
GM 65.97%
FCFM N/A
ROA(3y)-29.75%
ROA(5y)-28.61%
ROE(3y)N/A
ROE(5y)N/A
ROIC(3y)N/A
ROIC(5y)N/A
ROICexc(3y)N/A
ROICexc(5y)N/A
ROICexgc(3y)N/A
ROICexgc(5y)N/A
ROCE(3y)N/A
ROCE(5y)N/A
ROICexcg growth 3YN/A
ROICexcg growth 5YN/A
ROICexc growth 3YN/A
ROICexc growth 5YN/A
OM growth 3YN/A
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3Y-0.71%
GM growth 5Y1.49%
F-Score5
Asset Turnover0.48
Health
Industry RankSector Rank
Debt/Equity 4.14
Debt/FCF N/A
Debt/EBITDA N/A
Cap/Depr 205.37%
Cap/Sales 9.37%
Interest Coverage N/A
Cash Conversion N/A
Profit Quality N/A
Current Ratio 3.56
Quick Ratio 2.41
Altman-Z 0.6
F-Score5
WACC8.52%
ROIC/WACCN/A
Cap/Depr(3y)531.2%
Cap/Depr(5y)375.98%
Cap/Sales(3y)15.14%
Cap/Sales(5y)11.07%
Profit Quality(3y)N/A
Profit Quality(5y)N/A
High Growth Momentum
Growth
EPS 1Y (TTM)1.97%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%-50.63%
EPS Next Y29.38%
EPS Next 2Y27.25%
EPS Next 3Y24.91%
EPS Next 5Y25.95%
Revenue 1Y (TTM)0.53%
Revenue growth 3Y9.43%
Revenue growth 5Y13.13%
Sales Q2Q%41.05%
Revenue Next Year24.5%
Revenue Next 2Y24.66%
Revenue Next 3Y24.27%
Revenue Next 5Y33.73%
EBIT growth 1Y23.13%
EBIT growth 3YN/A
EBIT growth 5YN/A
EBIT Next Year55.54%
EBIT Next 3Y44.82%
EBIT Next 5Y49.98%
FCF growth 1Y34.48%
FCF growth 3YN/A
FCF growth 5YN/A
OCF growth 1Y33.89%
OCF growth 3YN/A
OCF growth 5YN/A